These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25756168)

  • 1. Effects of bovine lactoferrin to oral Candida albicans and Candida glabrata isolates recovered from the saliva in elderly people.
    Komatsu A; Satoh T; Wakabayashi H; Ikeda F
    Odontology; 2015 Jan; 103(1):50-5. PubMed ID: 25756168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bovine lactoferrin to oral Candida albicans and Candida glabrata isolates recovered from the saliva in elderly people.
    Komatsu A; Satoh T; Wakabayashi H; Ikeda F
    Odontology; 2013 Sep; ():. PubMed ID: 24077721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
    Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
    J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral epithelium-Candida glabrata interactions in vitro.
    Li L; Dongari-Bagtzoglou A
    Oral Microbiol Immunol; 2007 Jun; 22(3):182-7. PubMed ID: 17488444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Candida species to lactoferrin.
    Xu YY; Samaranayake YH; Samaranayake LP; Nikawa H
    Med Mycol; 1999 Feb; 37(1):35-41. PubMed ID: 10200932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic activity and cytokine up-regulation by non-albicans Candida albicans.
    Nawaz A; Pärnänen P; Kari K; Meurman JH
    Arch Microbiol; 2015 May; 197(4):533-7. PubMed ID: 25618435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
    Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
    Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Candida species in head and neck cancer patients treated by radiotherapy.
    de Freitas EM; Nobre SA; Pires MB; Faria RV; Batista AU; Bonan PR
    Auris Nasus Larynx; 2013 Aug; 40(4):400-4. PubMed ID: 23260345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin.
    Okutomi T; Abe S; Tansho S; Wakabayashi H; Kawase K; Yamaguchi H
    FEMS Immunol Med Microbiol; 1997 Jun; 18(2):105-12. PubMed ID: 9223614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models.
    Li L; Kashleva H; Dongari-Bagtzoglou A
    Microb Pathog; 2007 Apr; 42(4):138-47. PubMed ID: 17306958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility.
    Katiyar S; Pfaller M; Edlind T
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2892-4. PubMed ID: 16870797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior colonisation with Candida species fails to guide empirical therapy for candidaemia in critically ill adults.
    Troughton JA; Browne G; McAuley DF; Walker MJ; Patterson CC; McMullan R
    J Infect; 2010 Nov; 61(5):403-9. PubMed ID: 20849877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans.
    Samaranayake YH; Samaranayake LP; Wu PC; So M
    APMIS; 1997 Nov; 105(11):875-83. PubMed ID: 9393559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
    Clancy CJ; Huang H; Cheng S; Derendorf H; Nguyen MH
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2569-72. PubMed ID: 16801448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P; Makieło L; Horwatt-Bozyczko E
    Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Ernst EJ; Hollanbaugh JL; Miller JG; Pfaller MA; Diekema DJ
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):273-7. PubMed ID: 18024053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium.
    Silva S; Henriques M; Hayes A; Oliveira R; Azeredo J; Williams DW
    J Oral Pathol Med; 2011 May; 40(5):421-7. PubMed ID: 21158929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.